NCT02712957View on ClinicalTrials.gov

A Proof-of-Concept Study Assessing NEO6860 in Osteoarthritis Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 17, 2016

Study Completion Date

November 24, 2016

Conditions

PainOsteoarthritis of the Knee

Interventions

DRUG

NEO6860

TRPV1 antagonist

DRUG

NEO6860 placebo

Inactive substance

DRUG

Naproxen

NSAID

DRUG

Naproxen placebo

inactive substance

Trial Locations (3)

H2Y 1S1

Diex Recherche Montreal Inc, Montreal

H3P 3P1

Algorithme Pharma, Montreal

J1H 1Z1

Diex Recherche Sherbrooke Inc, Sherbrooke

Sponsors

Lead Sponsor

Neomed Institute

All Listed Sponsors

lead

Neomed Institute

OTHER